Nonmotor symptoms in subjects without evidence of dopaminergic deficits.

Mov Disord 2015 Jun 15;30(7):976-81. Epub 2015 Mar 15.

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Background: A subgroup of patients initially diagnosed with Parkinson's disease (PD) turn out to have normal dopamine transporter single-photon emission computed tomography imaging and have been labeled as subjects without evidence of dopaminergic deficit (SWEDDs). In this study, we sought to further characterize these patients and have analyzed the frequency of nonmotor symptoms (NMS) in SWEDDs, PD patients, and healthy controls.

Methods: We analyzed the baseline clinical data of 412 PD patients, 184 controls, and 62 SWEDDs included in the Parkinson's Progression Marker Initiative study on a variety of different NMS questionnaires.

Results: Both PD patients and SWEDDs had greater frequency of NMS than healthy controls. Furthermore, some NMS, such as orthostatic hypotension as well as cardiovascular and thermoregulatory dysfunction were even more commonly reported in SWEDDs than in PD patients, whereas hyposmia was more common in PD, compared to SWEDDs.

Conclusion: NMS are more frequent in SWEDDs than in controls, and autonomic dysfunction and orthostatic hypotension were even more common than in PD patients. These findings support the notion that SWEDDS represent a group of patients with still poorly understood pathophysiology. © 2015 International Parkinson and Movement Disorder Society.

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26204DOI Listing
June 2015
42 Reads

Publication Analysis

Top Keywords

subjects evidence
8
swedds patients
8
orthostatic hypotension
8
patients
8
evidence dopaminergic
8
nonmotor symptoms
8
swedds
7
nms
5
swedds greater
4
well cardiovascular
4
patients swedds
4
questionnairesresults patients
4
nms questionnairesresults
4
greater frequency
4
hypotension well
4
variety nms
4
controls nms
4
healthy controls
4
nms healthy
4
frequency nms
4

References

(Supplied by CrossRef)
Fahn S, Parkinson Study Group. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
J Neurol 2005
Long-term follow-up of patients with scans without evidence of dopaminergic deficit (SWEDD) in the ELLDOPA study
Marek et al.
Neurology 2005
Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland
Newman et al.
Mov Disord 2009
SWEDD for the general neurologist
Bajaj et al.
Adv Clin Neurosci Rehabil 2010

Similar Publications